Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 161 Neoplasm Metastasis 22 Neoplasms 20 Advanced Breast Cancer 13 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Hereditary Sensory and Autonomic Neuropathies 9 Endometrial Neoplasms 8 Triple Negative Breast Neoplasms 7 Colorectal Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Prostatic Neoplasms 5 Recurrence 4 Neoplasms by Site 4 Multiple Endocrine Neoplasia Type 1 4 Breast Diseases 4 Small Cell Lung Carcinoma 3 Head and Neck Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Locally Advanced (Inoperable) or Metastatic Breast Cancer 2 Liposarcoma 2 HER2-positive Metastatic Breast Cancer 2 Advanced Solid Tumors 2 Advanced Solid Tumor 2 Urologic Neoplasms 1

Interventions

ixabepilone 1 ST 1481 1 Paclitaxel 1 Fulvestrant 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Malignancies × Fulvestrant × Clear all

NCT02640755 2019-04-22

14C

AstraZeneca

Phase 1 Completed

4 enrolled 34 charts

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡